2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum

Bracing for Impact: 
Best Practices for Maintaining Pharmaceutical Supply Chain Continuity in a Complex and Dynamic Environment 

The 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference and Executive Forum provides you with access to regulatory intelligence on emerging supply chain, quality, and compliance challenges in light of COVID-19. Participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing global health authorities, including FDA and MHRA
 
Benefit from unparalleled real-time engagement with regulatory leaders as they share companies' best practices to assess critical manufacturing processes and lessons learned to improve and sustain a reliable supply of quality medicine. Plus, stay knowledgeable throughout the year with on demand access to ALL session recordings and presentations for 12 months.


Featured Regulators

Carmelo Rosa, PsyD
Director, Division of Drug Quality I
FDA/CDER/OC/OMQ
David Churchward
Deputy Unit Manager, Inspectorate Strategy & Innovation
MHRA
Letitia Robinson, PhD
Country Director, India Office
FDA/ORA
Placeholder Person Graphic
José E. Meléndez
Consumer Safety Officer
FDA/ORA
Placeholder Person Graphic
Christopher T. Middendorf
International Relations Specialist / Diplomat At FDA
FDA/OC
Sarah McMullen, PhD
Deputy Director
OC/FDA

Executive Forum*

Strategies for Supply Chain Visibility & Control

The Executive Forum, led by global regulators and industry leaders, is an interactive discussion forum for pharmaceutical executives.  The focus of this year’s Forum will be on post-COVID-19 assessment of the impact on the pharmaceutical supply chain and lessons learned for the pharmaceutical manufacturing industry.

Learning Objectives

Collaboratively explore opportunities facing pharmaceutical leaders and regulators to develop strategies for enhanced supply chain visibility and control.
 

Executive Forum Topics Include

  • Impact of COVID-19 on the pharmaceutical supply chain
  • Sustainable supply chain visibility & control strategies 
  • Post-COVID-19 assessment/lessons learned
  • Redundancy in facilities and operations
  • Supply chain security in times of crisis
  • Global regulatory agency interaction
  • Alternate inspection approaches

*The Forum is included with Conference Registration


Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda. Interested in two sessions happening at the same? We have you covered because you'll have access to all of the recordings from the event for one year.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3
  • Stay Current and Knowledgeable Throughout the Year
    In addition to expert insights, your tangible takeaways include access to the recording of ALL conference sessions and presentations for one year. Unlike an in-person event, you’ll get to experience the sessions you missed—that means both tracks! The recordings are also valuable as a refresher throughout the year.
    alt  4

Virtual Event FAQs


Conference Highlights


Learning Objectives

Attendees will be able to:

  • Assess the impact of COVID-19 on their company’s supply chain visibility and control
  • Apply lessons learned from companies impacted by the pandemic in their own organization
  • Become current on industry trends in quality & compliance as supply chains evolve
  • Work with CMOs to mitigate supply chain disruptions
  • Understand quality and regulatory requirements and expectations  
  • Understand the necessary elements and compliance for quality sustainability  

Who Should Attend?

Executive Level Leaders in Pharmaceutical and Biopharmaceutical Supply Chain

Manufacturing & Operations professionals Quality Assurance professionals Quality Control professionalsRegulatory Body personnel Regulatory Affairs experts Pharma Senior Level Managers


Program Committee

Carmelo Rosa, PsyD
Director, Division of Drug Quality I
FDA/CDER/OC/OMQ
Co-Chair
Frances M. Zipp
President & CEO
Lachman Consultant Services, Inc
Co-Chair and Board Ambassador
Antonio C. Crincoli, PE
Senior Director, Head Upjohn Global Engineering
Pfizer Inc.
Deva H. Puranam
Head of Global Quality Investigations
Mylan
Caroline Rocks, CEng
Senior Program Manager
AbbVie, Inc.